Disodium Lauramido Mea

Disodium Lauramido Mea

SCHEMBL3697471

CCCCCCCCCCCC(=O)NCCOC(=O)C(CC(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Disodium Lauramido Mea. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FGF1 known ✓ P05230 1/20 0.38
FAAH O00519 4/20 0.43
LPAR1 Q92633 2/20 0.41
LPAR2 Q9HBW0 2/20 0.41
ENPP2 Q13822 1/20 0.41
EPHX2 P34913 1/20 0.41
DNM1 Q05193 2/20 0.41
CPT2 P23786 1/20 0.41
CPT1A P50416 1/20 0.41
CPT1B Q92523 1/20 0.41
ALDH1A1 P00352 2/20 0.40
SELP P16109 1/20 0.40
CASP2 P42575 1/20 0.39
STS P08842 2/20 0.38
FGF2 P09038 1/20 0.38
HPSE Q9Y251 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29392097 0.94 LPAR1 (0.52) LPAR1LPAR2ENPP2EPHX2ALDH1A1
SCHEMBL3697476 0.92 EPHX2 (0.44) FAAHLPAR1LPAR2ENPP2EPHX2
SCHEMBL27943740 0.92 EPHX2 (0.44) FAAHLPAR1LPAR2ENPP2EPHX2
SCHEMBL28701810 0.92 EPHX2 (0.44) FAAHLPAR1LPAR2ENPP2EPHX2
SCHEMBL2727565 0.91 FAAH (0.43) FAAHLPAR1LPAR2ENPP2DNM1
SCHEMBL29391868 0.88 LPAR1 (0.48) LPAR1LPAR2ENPP2EPHX2ALDH1A1
SCHEMBL29383764 0.86 FAAH (0.55) FAAHLPAR1LPAR2ENPP2EPHX2
SCHEMBL9437697 0.85 EPHX2 (0.54) LPAR1LPAR2ENPP2EPHX2ALDH1A1
SCHEMBL29392942 0.85 CPT2 (0.37) FAAHEPHX2CPT2CPT1ACPT1B
SCHEMBL4809983 0.83 TSHR (0.45) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087745-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-30 WO disclosed
EP-4732825-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-29 EP disclosed
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS SYMRISE AG (DE) 2026-04-09 US disclosed
EP-4186969-B1 SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION HENKEL AG & CO KGAA (DE) 2026-04-01 EP disclosed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP disclosed
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 US disclosed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US disclosed
EP-4687810-A1 PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE Symrise AG (DE) 2026-02-11 EP disclosed
EP-4110276-B1 COMPOSITIONS COMPRISING ALKANEDIOLS SYMRISE AG (DE) 2026-01-28 EP disclosed
US-12534685-B2 Fragrance composition SYMRISE AG (DE) 2026-01-27 US disclosed
US-20220117881-A1 A HAIR CARE COMPOSITION SYMRISE AG (DE) 2022-04-21 US disclosed
EP-3982910-A1 A COOLING PREPARATION Symrise AG (DE) 2022-04-20 EP disclosed
WO-2022053140-A1 SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES SYMRISE AG (DE) 2022-03-17 WO disclosed
US-20220071872-A1 A LIQUID AND TRANSPARENT BLEND OF UV FILTERS SYMRISE AG (DE) 2022-03-10 US disclosed
US-20220047476-A1 A METHOD FOR FIGHTING FEMALE BODY ODORS SYMRISE AG (DE) 2022-02-17 US disclosed
CN-103356423-B Peel-off type tuckahoe facial mask and preparation method thereof SHANGHAI ZHENXIN CHEMICAL TECHNOLOGY CO LTD 2015-05-20 CN disclosed
CN-103361212-B Selfheal revitalizing compound perfumed soap SHANGHAI BAFANG FINE CHEMICAL ENG CO LTD 2014-12-17 CN disclosed
CN-103361212-A Selfheal revitalizing compound perfumed soap SHANGHAI BAFANG FINE CHEMICAL CO LTD 2013-10-23 CN disclosed
CN-103356423-A Peel-off type tuckahoe facial mask and preparation method thereof SHANGHAI ZHENXIN CHEMICAL TECHNOLOGY CO LTD 2013-10-23 CN disclosed
EP-2452669-A1 Ophthalmic composition Omnivision GmbH (DE) 2012-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534685-B2 Fragrance composition NCLN, HCN2, TRPA1 FGF1 4379/4885FAAH 726/4885LPAR1 4874/4885
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 FGF1 3899/4885FAAH 4153/4885LPAR1 1623/4885
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL RBP4, LRAT, RARB FGF1 3257/4885FAAH 660/4885LPAR1 709/4885
US-20220047476-A1 A METHOD FOR FIGHTING FEMALE BODY ODORS SHBG, C5, CUTA FGF1 3371/4885FAAH 547/4885LPAR1 618/4885
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS PTGS2, PTGES2, PTGS1 FGF1 112/4885FAAH 464/4885LPAR1 1695/4885
US-20220071872-A1 A LIQUID AND TRANSPARENT BLEND OF UV FILTERS F2, F12, TYR FGF1 993/4885FAAH 166/4885LPAR1 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.